Endocrine therapy considerations in postmenopausal patients with hormone receptor positive, human epidermal growth factor receptor type 2 negative advanced breast cancers

Por Migliaccio, Ilenia, Malorni, Luca, Hart, Christopher D, Guarducci, Cristina, Di Leo, Angelo
Publicado no BMC Med (2015)

Complex Regulation of the Cyclin-Dependent Kinase Inhibitor p27(kip1) in Thyroid Cancer Cells by the PI3K/AKT Pathway: Regulation of p27(kip1) Expression and Localization

Por Motti, Maria Letizia, Califano, Daniela, Troncone, Giancarlo, De Marco, Carmela, Migliaccio, Ilenia, Palmieri, Emiliano, Pezzullo, Luciano, Palombini, Lucio, Fusco, Alfredo, Viglietto, Giuseppe
Publicado em 2005

A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with...

Por Malorni, Luca, Piazza, Silvano, Ciani, Yari, Guarducci, Cristina, Bonechi, Martina, Biagioni, Chiara, Hart, Christopher D., Verardo, Roberto, Leo, Angelo Di, Migliaccio, Ilenia
Publicado no Oncotarget (2016)

p27(Kip1 )is expressed in proliferating cells in its form phosphorylated on threonine 187

Por Troncone, Giancarlo, Martinez, Juan C, Iaccarino, Antonino, Zeppa, Pio, Caleo, Alessia, Russo, Maria, Migliaccio, Ilenia, Motti, Maria L, Califano, Daniela, Palmieri, Emiliano A, Palombini, Lucio
Publicado em 2005

Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer

Por Migliaccio, Ilenia, Wu, Meng-Fen, Gutierrez, Carolina, Malorni, Luca, Mohsin, Syed K., Allred, D. Craig, Hilsenbeck, Susan G., Osborne, C. Kent, Weiss, Heidi, Lee, Adrian V.
Publicado em 2009

Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence

Por Smith, Carolyn L., Migliaccio, Ilenia, Chaubal, Vaishali, Wu, Meng-Fen, Pace, Margaret C., Hartmaier, Ryan, Jiang, Shiming, Edwards, Dean P., Gutiérrez, M. Carolina, Hilsenbeck, Susan G., Oesterreich, Steffi
Publicado em 2012

TransCONFIRM: Identification of a genetic signature of response to fulvestrant in advanced hormone receptor positive breast cancer

Por Jeselsohn, Rinath, Barry, William T., Migliaccio, Ilenia, Biagioni, Chiara, Zhao, Jin, De Tribolet-Hardy, Jonas, Guarducci, Cristina, Bonechi, Martina, Laing, Naomi, Winer, Eric P., Brown, Myles, Di Leo, Angelo, Malorni, Luca
Publicado no Clin Cancer Res (2016)

Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: a Randomized Phase II Study

Por Osborne, C. Kent, Neven, Patrick, Dirix, Luc Y., Mackey, John R., Robert, Jean, Underhill, Craig, Schiff, Rachel, Gutierrez, Carolina, Migliaccio, Ilenia, Anagnostou, Valsamo K., Rimm, David L., Magill, Patrick, Sellers, Mark
Publicado em 2011

Upregulation of Mucin4 in ER-positive/HER2-Overexpressing Breast Cancer Xenografts with Acquired Resistance to Endocrine and HER2-Targeted Therapies

Por Chen, Albert C., Migliaccio, Ilenia, Rimawi, Mothaffar, Lopez-Tarruella, Sara, Creighton, Chad J., Massarweh, Suleiman, Huang, Catherine, Wang, Yen-Chao, Batra, Surinder K., Gutierrez, M. Carolina, Osborne, C. Kent, Schiff, Rachel
Publicado em 2012

Reduced Dose and Intermittent Treatment with Lapatinib and Trastuzumab for Potent Blockade of the HER Pathway in HER-2/neu Overexpressing Breast Tumor Xenografts

Por Rimawi, Mothaffar F., Wiechmann, Lisa S., Wang, Yen-Chao, Huang, Catherine, Migliaccio, Ilenia, Wu, Meng-Fen, Gutierrez, Carolina, Hilsenbeck, Susan G., Arpino, Grazia, Massarweh, Suleiman, Ward, Robin, Soliz, Robert, Osborne, C. Kent, Schiff, Rachel
Publicado em 2010

Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Lo...

Por Dave, Bhuvanesh, Migliaccio, Ilenia, Gutierrez, M. Carolina, Wu, Meng-Fen, Chamness, Gary C., Wong, Helen, Narasanna, Archana, Chakrabarty, Anindita, Hilsenbeck, Susan G., Huang, Jian, Rimawi, Mothaffar, Schiff, Rachel, Arteaga, Carlos, Osborne, C. Kent, Chang, Jenny C.
Publicado em 2011

Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance

Por Malorni, Luca, Giuliano, Mario, Migliaccio, Ilenia, Wang, Tao, Creighton, Chad J., Lupien, Mathieu, Fu, Xiaoyong, Hilsenbeck, Susan G., Healy, Nuala, De Angelis, Carmine, Mazumdar, Abhijit, Trivedi, Meghana V., Massarweh, Suleiman, Gutierrez, Carolina, De Placido, Sabino, Jeselsohn, Rinath, Brown, Myles, Brown, Powel H., Osborne, C. Kent, Schiff, Rachel
Publicado no Mol Cancer Res (2016)

The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor

Por Karlin, Kristen L., Mondal, Gourish, Hartman, Jessica K., Tyagi, Siddhartha, Kurley, Sarah J., Bland, Chris S., Hsu, Tiffany Y.T., Renwick, Alexander, Fang, Justin E., Migliaccio, Ilenia, Callaway, Celetta, Nair, Amritha, Dominguez-Vidana, Rocio, Nguyen, Don X., Osborne, C. Kent, Schiff, Rachel, Yu-Lee, Li-Yuan, Jung, Sung Y., Edwards, Dean P., Hilsenbeck, Susan G., Rosen, Jeffrey M., Zhang, Xiang, Shaw, Chad A., Couch, Fergus J., Westbrook, Thomas F.
Publicado no Cell Rep (2014)